MedPath

A new material for treatment of single receding gums

Not Applicable
Conditions
Gingival recession
Oral Health
Registration Number
ISRCTN15571664
Lead Sponsor
Damascus University
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Ongoing
Sex
All
Target Recruitment
30
Inclusion Criteria

1. Good general health.
2. No contraindications for periodontal surgery.
3. Presence one localized gingival recession in each side of the maxilla and/or mandible, All recessions will be Class I or II defects (Miller 1985).
4. The cemento–enamel junction (CEJ) will be visible in the teeth for root coverage procedures.
5. All patients demonstrating adequate plaque control.
6. All patients will be at least 18 years of age.
7. No previous periodontal surgery in the area.

Exclusion Criteria

1. Patients smoking more than 10 cigarettes per day.
2. Patients with insulin-dependent diabetes.
3. Patients with a history of malignancy, radiotherapy, or chemotherapy for malignancy.
4. Patient pregnant or nursing during the past 5 months.
5. Patients taking medications or having treatments with an effect on mucosal healing in general (e.g. steroids, large doses of anti inflammatory drugs).
6. Patients with a disease affecting connective tissue metabolism.
7. Patients allergic to collagen.
8. Presence more than one localized gingival recession in each side of the maxilla and/or mandible.

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
<br> 1. Gingival recession depth measured using a UNC-15 probe at baseline, 1, 3, 6 months<br> 2. Gingival recession width measured using a UNC-15 probe at baseline, 1, 3, 6 months<br> 3. Keratinized Tissue Thickness measured using an anesthesia needle attached to a silicone disc stop at base line, 3 , 6 months.<br>
Secondary Outcome Measures
NameTimeMethod
<br> 1. Probing depth measured using a UNC-15 probe at baseline, 3, 6 months<br> 2. Relative attachment level measured using a UNC-15 probe at baseline, 3, 6 months<br> 3. Keratinized tissue height measured using a UNC-15 probe at baseline, 3, 6 months<br> 4. Healing measured using a healing index at 1, 2 weeks and 1 month after surgery<br> 5. Plaque presence measured using a plaque index at baseline, 1, 3, 6, months<br> 6. Pain measured using a visual analogue scale (VAS) at 1 week after surgery<br> 7. Bleeding measured using a visual analogue scale (VAS) at 1 week after surgery<br> 8. Dentine hypersensitivity measured using a visual analogue scale (VAS) at baseline, 1, 3, 6 months<br>
© Copyright 2025. All Rights Reserved by MedPath